115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12932)
  10. Department of Pathology and Laboratory Medicine (12602)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1224)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CLARITY-Gastric 01: A randomized phase 3 study of AZD0901, a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC)
    Meeting Abstract

    Janjigian, Y. Y.; Shitara, K.; Elimova, E.; Zhang, J.; Chen, M. H.; Smyth, E. C.; Lee, J.; Miao, R.; Liu, S.; Holmblad, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Co-formulated favezelimab plus pembrolizumab versus standard-of-care in previously treated, PD-L1-positive metastatic colorectal cancer: The phase 3, randomized KEYFORM-007 study
    Meeting Abstract

    Segal, N. H.; Passhak, M.; Köse, F.; Kubala, E.; Elez, E.; Kawakami, H.; Guren, M. G.; Jonker, D. J.; Xu, R. H.; Riera, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (alliance)/SWOG 80702
    Meeting Abstract

    Nowak, J. A.; Shi, Q.; Twombly, T.; Pederson, L. D.; Ma, C.; Väyrynen, J. P.; Zhao, M. M.; Takashima, Y.; Shergill, A.; Kumar, P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors
    Meeting Abstract

    Spira, A. I.; Papadopoulos, K. P.; Kim, D. W.; Parikh, A. R.; Barve, M. A.; Powderly, J. D. 2nd; Starodub, A.; Strickler, J. H.; Li, B. T.; Oberstein, P. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Genomic analysis of paired primary and metastatic pancreatic ductal adenocarcinoma tumors
    Meeting Abstract

    McIntyre, C. A.; Rudneva, V.; Richards, A. L.; Park, W.; Jarnagin, W. R.; Donoghue, M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Peak part 1 summary: A phase 3, randomized, open-label, multicenter clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Trent, J. C.; Wagner, A. J.; Attia, S.; Agulnik, M.; Wilky, B. A.; Tap, W. D.; von Mehren, M.; Davis, E. J.; Zou, L.; Shah, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2+ advanced solid tumors
    Meeting Abstract

    Dumbrava, E. E.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of dose adjustments on overall survival (OS) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with NALIRIFOX: A post hoc analysis of NAPOLI 3
    Meeting Abstract

    Patel, A. J.; Laursen, A. A.; Cockrum, P.; Liu, Y.; Surinach, A.; Rhodes, W.; Zhang, L.; Li, J.; Maxwell, F.; Wainberg, Z. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP) Bayesian platform trial
    Meeting Abstract

    Picozzi, V. J.; Varghese, A. M.; Oberstein, P. E.; Hidalgo, M.; Wolpin, B. M.; Lim, K. H.; McGlothlin, A.; Graves, T.; Detry, M. A.; Fitzgerald, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of UGT1A1*28 polymorphism on tolerability in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with NALIRIFOX in NAPOLI 3
    Meeting Abstract

    Abdelrahim, M.; Khan, G.; Hatoum, H.; Zervoudakis, A.; Dayyani, F.; Zhang, L.; Li, J.; Maxwell, F.; O'Reilly, E. M.; Wainberg, Z. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save